You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
27 August 2026 - US biopharmaceutical company AbbVie (NYSE: ABBV) announced on Thursday that it has applied to the European Medicines Agency for approval of subcutaneous induction dosing of SKYRIZI (risankizumab) for adults with moderately to severel...
27 August 2026 - Biopharmaceutical companies AstraZeneca plc (STO:AZN) (LON:AZN) (NYSE:AZN) and Amgen Inc (NASDAQ:AMGN) on Thursday reported positive results from the Phase III CROSSING trial showing that Tezspire (tezepelumab) delivered statisticall...
27 August 2026 - Swedish clinical-stage biotech company Oxcia AB, which develops therapies targeting oxidative stress and DNA damage response pathways, announced on Thursday that the European Medicines Agency has made the decision to grant Orphan Dru...
27 August 2026 - Clinical-stage biotechnology company Graviton BioScience Corporation announced on Wednesday the publication of peer-reviewed data from a multicentre Phase Ib/II multi-dose, open-label clinical trial evaluating the safety, tolerabilit...
27 August 2026 - Cizzle Bio Inc, a biotechnology company advancing biomarker blood tests for early cancer detection, announced on Wednesday its participation in the 18th Annual Next Generation Dx Summit in Washington, D.C.On Monday, Dr. Lary A. Robin...
27 August 2026 - Swiss healthcare company Roche (SIX: RO, ROG; OTCQX: RHHBY) announced on Wednesday that it has received FDA approval for expanded use of its PATHWAY HER2 (4B5) and VENTANA HER2 Dual ISH DNA Probe Cocktail tests.These companion diagno...
26 August 2026 - Japanese healthcare company Daiichi Sankyo Co Ltd (TYO:4568) announced on Wednesday that the first patient has been dosed in the phase 3 TROPION-Urothelial04 trial evaluating Datroway (datopotamab deruxtecan) as an adjuvant treatment...